TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 41 filers reported holding TRANSPHORM INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $555,187 | -35.5% | 250,084 | -1.2% | 0.78% | -19.3% |
| Q2 2023 | $860,486 | -14.8% | 253,084 | 0.0% | 0.97% | -17.6% |
| Q1 2023 | $1,009,805 | -25.5% | 253,084 | +1.6% | 1.18% | -28.6% |
| Q4 2022 | $1,355,017 | +7.4% | 249,084 | -0.7% | 1.65% | +20.3% |
| Q3 2022 | $1,262,000 | +32.0% | 250,944 | 0.0% | 1.37% | +41.9% |
| Q2 2022 | $956,000 | -63.9% | 250,944 | -32.9% | 0.97% | -40.0% |
| Q1 2022 | $2,646,000 | – | 374,226 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 3,772,875 | $18,978,000 | 5.90% |
| Worth Venture Partners, LLC | 911,237 | $4,584,000 | 2.81% |
| Kohlberg Kravis Roberts & Co. L.P. | 22,675,980 | $114,060,000 | 2.29% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 250,944 | $1,262,000 | 1.37% |
| Soros Fund Management | 673,991 | $3,390,000 | 0.06% |
| Polar Asset Management Partners Inc. | 709,700 | $3,570,000 | 0.04% |
| AMERIPRISE FINANCIAL INC | 3,805,595 | $19,142,000 | 0.01% |
| Stratos Wealth Partners, LTD. | 30,000 | $151,000 | 0.00% |
| FMR LLC | 886 | $4,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 10,801 | $54,000 | 0.00% |